Medical nutrition therapy as a potential complementary treatment for psoriasis—five case reports

Alternative Medicine Review, Sept, 2004 by Amy C. Brown, Michelle Hairfield, Douglas G. Richards, David L. McMillin, Eric A. Mein, Carl D. Nelson

(43.) Juby LD, Rothwell J, Axon AT. Lactulose/ mannitol test: an ideal screen for celiac disease. Gastroenterology 1989;96:79-85.

(44.) van Elburg RM, Uil JJ, Kokke FT, et al. Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J Pediatr Gastroenterol Nutr 1995;20:184-188.

(45.) Klaber M. Common Skin Conditions in General Practice. Surrey, United Kingdom: Reed Business Publishing; 1991.

(46.) Voorhees JJ, Duell EA. Imbalanced cyclic AMP-cyclic GMP levels in psoriasis. Adv Cyclic Nucleotide Res 1975;5:735-758.

(47.) Proctor MS, Wilkinson DI, Orenberg EK, Farber EM. Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis. Arch Dermatol 1979;115:945-949.

(48.) Voorhees JJ. Polyamines and psoriasis. Arch Dermatol 1979;115:943-944.

(49.) McDonald CJ. Polyamines in psoriasis. J Invest Dermatol 1983;81:385-387.

(50.) Kaplan RP, Russell DH, Lowe NJ. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. J Am Acad Dermatol 1983;8:95-102.

(51.) Grekin RC, Ellis CN, Goldstein NG, et al. Decreased urinary polyamines in patients with psoriasis treated with etretinate. J Invest Dermatol 1983;80:181-184.

(52.) Rosenberg EW, Belew PW. Microbial factors in psoriasis. Arch Dermatol 1982;118:143-144.

(53.) Hao WL, Lee YK. Microflora of the gastrointestinal tract: a review. Methods Mol Biol 2004;268:491-502.

(54.) Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Altern Med Rev 2001;6:540-566.

(55.) Bittiner SB, Tucker WF, Cartwright I, Bleehen SS. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988;1:378-380.

(56.) Collier PM, Payne CR. The dietary effect of oily fish consumption on psoriasis. Br J Dermatol 1996;135:858.

(57.) Maurice PD, Allen BR, Barkley AS, et al. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987;117:599-606.

(58.) Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind multicentre study. Br J Dermatol 1994;130:757-764.

(59.) Bjorneboe A, Smith AK, Bjorneboe GE, et al. Effect of dietary supplementation with n-3 fatty acids on clinical manifestations of psoriasis. Br J Dermatol 1988;118:77-83.

(60.) Voorhees JJ. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 1983;119:541-547.

(61.) Adam O. Dietary fatty acids and immune reactions in synovial tissue. Eur J Med Res 2003;8:381-387.

(62.) Grimminger F, Mayser P, Papavassilis C, et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Investig 1993;71:634-643.

(63.) Xu SX. Anti-inflammatory active constituents of Carthamus tinctorius (2). Zhong Yao Tong Bao 1986;11:42-44. [Article in Chinese]